Brian Feroldi

Brian Feroldi


Brian Feroldi has been covering the healthcare and technology industries for the Motley Fool since 2015. Brian's investing goal is to find the highest quality companies that he can find, buy them, and then to sit back and let compounding work its magic. See all of his articles here and make sure you follow him on Twitter.

Recent articles

Why New Relic Is Falling Today

Shares sink after the company announces a management shakeup and cuts its full-year guidance. Here's what investors need to know.

Why Duluth Holdings Is Down Big Today

Shares sink after the company reports disappointing quarterly results and provides downbeat guidance. Here are the must-know details for investors.

Why Durect Stock Is Up Today

Investors bid up the share price after the company received some bullish praise from a Wall Street pro.

Why Ardelyx Is Soaring Today

Shares jump after the clinical-stage biotech reports encouraging results from an important late-stage trial.

Synopsys' Growth Accelerates

The semiconductor software specialist raises its full-year guidance again after another strong quarter.